ブログ

U.S. Department of Transportation Office of Drug and Alcohol Policy and Compliance (ODAPC) Publishes List Serve Notice on the Revised CCF

Just made available is the ODAPC Notice from its List Serve on the Revised CCF. It is easy to subscribe to DOT’s List Serve. Just click on the following and follow the steps.https://www.transportation.gov/odapc/ListServe_Notices

This is to call your attention to the DOT Guidance on the Revised Federal Drug Testing Custody and Control Form following also  found at the following link:  https://www.transportation.gov/odapc/Notice_CCF_August_2020.

This guidance document discusses changes to the revised Federal Drug Testing Custody and Control Form (CCF), which was approved by the Office of Management and Budget (OMB) on August 17, 2020.  The revised CCF can be viewed here.

How will I know the difference between the old CCF and the revised CCF?

The old CCF is the one that has been used under the DOT-regulated program since 2017.

Most of the changes adopted in the revised CCF were made to accommodate the use of oral fluid specimens for the Federal drug testing program.  Oral fluid drug testing is not authorized in DOT’s current drug testing program.

In addition to the changes regarding oral fluids, the revised CCF also includes the following changes:

  • Copies 1-5, Step 1:  Added “CDL State and No.” to donor identification (FMCSA only);
  • Copies 1-5, Step 1:  Added “Other” (i.e., e-mail) to Collector Contact Info;
  • Copy 1, Step 5a:  Removed analyte names and checkboxes; repositioned results and checkboxes; and added a line for the certifying scientist to record the positive analyte(s) and concentration(s) if a positive result is recorded;
  • Copies 2-5, Step 5:  Added a line for the donor e-mail address;
  • Copy 5:  Removed instructions for completing the CCF from the back of the form. Instructions for completing the CCF are posted on the SAMHSA https://www.samhsa.gov/workplace/drug-testing and ODAPC https://www.transportation.gov/odapc/documents websites.

When can I begin using the revised CCF?

DOT-regulated employers and their service agents (collectors, laboratories, Medical Review Officers (MRO)) are authorized to use the revised CCF beginning September 1, 2020.  To avoid confusion regarding whether oral fluid testing is authorized in the DOT program, and to allow existing supplies of old CCFs to be depleted, we recommend as a best practice that laboratories not mail any of the revised CCFs to DOT-regulated clients or their service agents until after June 1, 2021 (or until supplies of the old CCFs have been depleted).

As a collector, can I still use the old CCF after September 1, 2020?

  • Yes. OMB authorized, and you may choose to use, the old CCF until August 30, 2021.  When using the old CCF between September 1, 2020, and August 30, 2021, a memorandum for the record (MFR) is not required.  If you use the old CCF after August 30, 2021, you must complete a MFR per 49 CFR § 40.205(b)(2).
  • Beginning September 1, 2020, you may use the revised CCF.  However, after August 30, 2021, you are required to use the revised CCF.  
  • We recommend that you monitor your existing supply of old CCFs and coordinate the delivery of the revised CCF with the testing laboratory.

If I use the old CCF between September 1, 2020, and August 30, 2021, do I need to do anything differently?

No.  The new information required to be provided on the revised CCF (i.e., collector and donor e-mail addresses) may be, but is not required to be, included when using the old CCF.

 ODAPC Guidance Document #: ODAPC DRG05

[1] This guidance does not have the force and effect of law and is not meant to bind the public in any way. This guidance is intended only to provide clarity to the public regarding existing requirements under the law. 

 Last updated: Monday, August 31, 2020

本情報は、情報共有のみを目的として提供されます。 First Advantageは法律を専門とする企業ではなく、本情報は法律上のアドバイスではなく、アドバイスを意図するものでもありません。本情報は最新の情報に更新されていない可能性がございます。

本情報の読者は、ご自身の特定の状況に応じて、ご自身の法律専門家にご相談ください。いかなる人も、本情報に基づいて行動したり、行動を控えるべきではありません。ご自身の弁護士、または法的アドバイザーのみが、こちらに含まれる情報とその解釈があなたの特定の状況に適用可能または適切であることを保証することができます。

本情報の利用及びアクセスによって、本プレゼンテーションの読者、またはユーザーとFirst Advantageとの間に弁護士-クライアント関係を創出することはありません。